- October 2020
- Clinical trials: new rules for conflict of interests
- EMA launches public consultation on the draft Guideline concerning registry-based studies
- The Italian Data Protection Authority publishes Frequently Asked Questions and Infographic on the Electronic Health Record
- Clinical trials: National Coordination Center of Ethics Committees issues Guidelines for the collection of informed consent
- Ecommerce of medicines: the European Court of Justice states the applicability of certain restrictions imposed by a Member State destination of ecommerce upon a provider established in another Member State
- Telemedicine: Lombardia and Piemonte give the green light to televisits
- Remote clinical trials: from emergency to new normal
- September 2020
- Life Sciences M&A trends: earnout clauses, general outlook, and a few drafting tips
- July 2020
- Supplementary protection certificates and Court of Justice: clarifications on the conditions for obtaining a supplementary protection certificate
- June 2020
- Acquisitions of companies involved in the medical devices business fall under the Italian foreign investment control
- Venture Capital watch: how COVID-19 is affecting and will affect VC transactions with a specific focus on the life sciences and healthcare sectors
- Masks, disinfectants, and serological tests: regulatory issues relating to products to be used in phases 2 and 3 of the emergency period
- The new CJEU judgment on Regulation No. 469/2009/EC, in Royalty Pharma case C- 650/17 and the role of independent inventive activity
- Italian Competition Authority approves two emergency cooperation projects: one for joint distribution of surgical masks and one common moratorium scheme on consumer lending
- Health Claims on Botanicals: according to the Council of State, unauthorized claims may be used if scientifically proven
- May 2020
- Italy: Garante's crackdown on patient health data protection
- COVID-19 emergency and processing of health data for scientific research purposes
- April 2020
- Medical Devices Regulation: EU Commission proposes a one year postponement of the application date
- COVID-19 emergency: increasingly dematerialized prescriptions
- AIFA: latest indications for "remote" clinical trials during the COVID-19 health emergency